No Data
No Data
Generation Bio (GBIO) Gets a Buy From Needham
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference
Express News | Generation Bio Granted U.S. Patent #12263228 : Lipids and Compositions Thereof
Wedbush Keeps Their Buy Rating on Generation Bio (GBIO)
Generation Bio Is Maintained at Buy by Canaccord Genuity
Generation Bio Price Target Maintained With a $9.00/Share by Canaccord Genuity